![S. Michael Imperiale](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
S. Michael Imperiale
Corporate Officer/Principal chez
PARADIGM BIOPHARMACEUTICALS LIMITED
Profil
S.
Michael Imperiale is currently the Chief Safety Officer at Paradigm Biopharmaceuticals Ltd. He previously worked as the Senior Director-Medical Sciences at Nuvelo, Inc. from 2004 to 2007.
He also held positions as the Senior Director-Global Medical Affairs at BioMarin Pharmaceutical, Inc., Director-Clinical Science at InterMune, Inc., Director-Clinical Trials Development at Exelixis, Inc., and Independent Director at ScripsAmerica, Inc. Additionally, he served as the Senior Associate Director-Clinical Scientific at Boehringer Ingelheim Pharmaceuticals, Inc. from 2000 to 2004.
From 2007 to 2009, he was the Vice President-Clinical Research Operations at Talon Therapeutics, Inc. Dr. Imperiale obtained his undergraduate degree from Villanova University in 1982 and his doctorate degree from Hahnemann University in 1987.
Postes actifs de S. Michael Imperiale
| Sociétés | Poste | Début |
|---|---|---|
| PARADIGM BIOPHARMACEUTICALS LIMITED | Corporate Officer/Principal | 01/06/2020 |
Anciens postes connus de S. Michael Imperiale
| Sociétés | Poste | Fin |
|---|---|---|
Talon Therapeutics, Inc.
 Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Directeur Technique/Scientifique/R&D | 01/01/2009 |
Nuvelo, Inc.
 Nuvelo, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic drugs using genomic technologies | Directeur Technique/Scientifique/R&D | 01/01/2006 |
| EXELIXIS, INC. | Corporate Officer/Principal | 01/01/2006 |
Boehringer Ingelheim Pharmaceuticals, Inc.
 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals products | Corporate Officer/Principal | 01/01/2004 |
| INTERMUNE INC | Directeur Technique/Scientifique/R&D | - |
Formation de S. Michael Imperiale
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
85
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Nuvelo, Inc.
Nuvelo, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic drugs using genomic technologies | Health Technology |
BioMarin Pharmaceutical, Inc.
 BioMarin Pharmaceutical, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions | Health Technology |
InterMune, Inc.
 InterMune, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that researches and develops therapies in pulmonology & orphan fibrotic diseases | Health Technology |
Exelixis, Inc.
 Exelixis, Inc. Pharmaceuticals: MajorHealth Technology Operates as a cancer drug discovery company | Health Technology |
ScripsAmerica, Inc.
 ScripsAmerica, Inc. Medical DistributorsDistribution Services Distributes pharmaceutical products | Distribution Services |
Talon Therapeutics, Inc.
Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
Villanova University
 Villanova University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals products | Health Technology |
Hahnemann University
 Hahnemann University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Paradigm Biopharmaceuticals Ltd.
 Paradigm Biopharmaceuticals Ltd. Pharmaceuticals: GenericHealth Technology Engages in repurposing the drug, pentosan polysulphate sodium for the treatment of bone marrow edema | Health Technology |
